These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

779 related articles for article (PubMed ID: 12540621)

  • 1. Effects of insulin resistance and type 2 diabetes on lipoprotein subclass particle size and concentration determined by nuclear magnetic resonance.
    Garvey WT; Kwon S; Zheng D; Shaughnessy S; Wallace P; Hutto A; Pugh K; Jenkins AJ; Klein RL; Liao Y
    Diabetes; 2003 Feb; 52(2):453-62. PubMed ID: 12540621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipoprotein subclass measurements by nuclear magnetic resonance spectroscopy improve the prediction of coronary artery disease in Type 1 diabetes. A prospective report from the Pittsburgh Epidemiology of Diabetes Complications Study.
    Soedamah-Muthu SS; Chang YF; Otvos J; Evans RW; Orchard TJ;
    Diabetologia; 2003 May; 46(5):674-82. PubMed ID: 12743701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adiponectin is associated with favorable lipoprotein profile, independent of BMI and insulin resistance, in adolescents.
    Magge SN; Stettler N; Koren D; Levitt Katz LE; Gallagher PR; Mohler ER; Rader DJ
    J Clin Endocrinol Metab; 2011 May; 96(5):1549-54. PubMed ID: 21367935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin resistance and adiposity influence lipoprotein size and subclass concentrations. Results from the Insulin Resistance Atherosclerosis Study.
    Goff DC; D'Agostino RB; Haffner SM; Otvos JD
    Metabolism; 2005 Feb; 54(2):264-70. PubMed ID: 15690322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipoprotein particles and incident type 2 diabetes in the multi-ethnic study of atherosclerosis.
    Mackey RH; Mora S; Bertoni AG; Wassel CL; Carnethon MR; Sibley CT; Goff DC
    Diabetes Care; 2015 Apr; 38(4):628-36. PubMed ID: 25592196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of insulin resistance on lipoprotein subpopulation distribution in lean and morbidly obese nondiabetic women.
    MacLean PS; Vadlamudi S; MacDonald KG; Pories WJ; Houmard JA; Barakat HA
    Metabolism; 2000 Mar; 49(3):285-92. PubMed ID: 10726902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of obesity on the plasma lipoprotein subclass profile in normoglycemic and normolipidemic men and women.
    Magkos F; Mohammed BS; Mittendorfer B
    Int J Obes (Lond); 2008 Nov; 32(11):1655-64. PubMed ID: 18779822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Lipoproteins, Insulin Resistance, and Rosuvastatin With Incident Type 2 Diabetes Mellitus : Secondary Analysis of a Randomized Clinical Trial.
    Dugani SB; Akinkuolie AO; Paynter N; Glynn RJ; Ridker PM; Mora S
    JAMA Cardiol; 2016 May; 1(2):136-45. PubMed ID: 27347563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of marine n-3 fatty acid supplementation on lipoprotein subclasses measured by nuclear magnetic resonance in subjects with type II diabetes.
    Mostad IL; Bjerve KS; Lydersen S; Grill V
    Eur J Clin Nutr; 2008 Mar; 62(3):419-29. PubMed ID: 17327864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nuclear magnetic resonance lipoprotein abnormalities in prediabetic subjects in the Insulin Resistance Atherosclerosis Study.
    Festa A; Williams K; Hanley AJ; Otvos JD; Goff DC; Wagenknecht LE; Haffner SM
    Circulation; 2005 Jun; 111(25):3465-72. PubMed ID: 15983261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relation of lipoprotein subclasses as measured by proton nuclear magnetic resonance spectroscopy to coronary artery disease.
    Freedman DS; Otvos JD; Jeyarajah EJ; Barboriak JJ; Anderson AJ; Walker JA
    Arterioscler Thromb Vasc Biol; 1998 Jul; 18(7):1046-53. PubMed ID: 9672064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pioglitazone and rosiglitazone have different effects on serum lipoprotein particle concentrations and sizes in patients with type 2 diabetes and dyslipidemia.
    Deeg MA; Buse JB; Goldberg RB; Kendall DM; Zagar AJ; Jacober SJ; Khan MA; Perez AT; Tan MH;
    Diabetes Care; 2007 Oct; 30(10):2458-64. PubMed ID: 17595355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-density lipoprotein particle size, triglyceride-rich lipoproteins, and glucose tolerance in non-diabetic men with essential hypertension.
    Rubies-Prat J; Ordóñez-Llanos J; Martin S; Blanco-Vaca F; Molina L; Goday A; Pedro-Botet J
    Clin Exp Hypertens; 2001 Aug; 23(6):489-500. PubMed ID: 11478431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipoprotein subclasses and particle sizes and their relationship with coronary artery calcification in men and women with and without type 1 diabetes.
    Colhoun HM; Otvos JD; Rubens MB; Taskinen MR; Underwood SR; Fuller JH
    Diabetes; 2002 Jun; 51(6):1949-56. PubMed ID: 12031985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipoprotein subclass profiles in individuals with varying degrees of glucose tolerance: a population-based study of 9399 Finnish men.
    Wang J; Stančáková A; Soininen P; Kangas AJ; Paananen J; Kuusisto J; Ala-Korpela M; Laakso M
    J Intern Med; 2012 Dec; 272(6):562-72. PubMed ID: 22650159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemoglobin level and lipoprotein particle size.
    Hämäläinen P; Saltevo J; Kautiainen H; Mäntyselkä P; Vanhala M
    Lipids Health Dis; 2018 Jan; 17(1):10. PubMed ID: 29321013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipoprotein particle subclass profiles among metabolically healthy and unhealthy obese and non-obese adults: does size matter?
    Phillips CM; Perry IJ
    Atherosclerosis; 2015 Oct; 242(2):399-406. PubMed ID: 26277632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sex and age differences in lipoprotein subclasses measured by nuclear magnetic resonance spectroscopy: the Framingham Study.
    Freedman DS; Otvos JD; Jeyarajah EJ; Shalaurova I; Cupples LA; Parise H; D'Agostino RB; Wilson PW; Schaefer EJ
    Clin Chem; 2004 Jul; 50(7):1189-200. PubMed ID: 15107310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of atorvastatin on serum lipids, lipoproteins and NMR spectroscopy defined lipoprotein subclasses in type 2 diabetic patients with ischaemic heart disease.
    Soedamah-Muthu SS; Colhoun HM; Thomason MJ; Betteridge DJ; Durrington PN; Hitman GA; Fuller JH; Julier K; Mackness MI; Neil HA;
    Atherosclerosis; 2003 Apr; 167(2):243-55. PubMed ID: 12818407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum n-6 fatty acids and lipoprotein subclasses in middle-aged men: the population-based cross-sectional ERA-JUMP study.
    Choo J; Ueshima H; Curb JD; Shin C; Evans RW; El-Saed A; Kadowaki T; Okamura T; Nakata K; Otake T; Miura K; Abbott RD; Sutton-Tyrrell K; Edmundowicz D; Kuller LH; Sekikawa A;
    Am J Clin Nutr; 2010 May; 91(5):1195-203. PubMed ID: 20357040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.